Skip to main content

Featured

Budget 2026 Lands Nov. 5: What to Do (and Not Do) With Your RRSP and TFSA First

  CANADIAN MONEY BRIEF  |  FEATURE  |  OCT. 23, 2026 The federal budget is 13 days away, tax-reform calls are getting louder, and “act now” headlines are about to pile up. Here’s what is actually confirmed, what is just lobbying, and what to leave alone. Finance Minister François-Philippe Champagne told the House of Commons on Oct. 20 that Budget 2026 will be tabled on Nov. 5 . It is the second budget since the Liberals moved the fiscal plan to the fall, and it lands two days after the U.S. midterm elections. Between now and then, expect a flood of speculation about RRSPs, TFSAs and capital gains. Before you move a dollar, it helps to separate three things: what’s confirmed, what’s being asked for, and what the rules say today. Key dates on your calendar Oct. 28 Bank of Canada rate decision (9:45 a.m. ET) Oct. 29 Ontario fall economic statement Nov. 3 U.S. midterm elections Nov. 5 Federal Budget 2026 Dec. 9 Final Bank of Canada decision of 2026 Mar. 1, 2027 RRSP...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment